BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10800158)

  • 1. The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.
    Bellantuono I; Lashford LS; Rafferty JA; Fairbairn LJ
    Haematologica; 2000 May; 85(5):451-7. PubMed ID: 10800158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
    Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
    Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H; Ishibashi F
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H; Ishibashi F
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton conduction through full-length gp91phox requires histidine 115.
    Mankelow TJ; Henderson LM
    Protoplasma; 2003 May; 221(1-2):101-8. PubMed ID: 12768347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
    Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
    Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
    Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.
    Giaretta I; Madeo D; Bonaguro R; Cappellari A; Rodeghiero F; Giorgio P
    Haematologica; 2000 Jul; 85(7):680-9. PubMed ID: 10897118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
    Kobinger GP; Mouland AJ; Lalonde JP; Forget J; Cohen EA
    Gene Ther; 1997 Aug; 4(8):868-74. PubMed ID: 9338017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
    Markowitz DG; Goff SP; Bank A
    Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term high-level reconstitution of NADPH oxidase activity in murine X-linked chronic granulomatous disease using a bicistronic vector expressing gp91phox and a Delta LNGFR cell surface marker.
    Sadat MA; Pech N; Saulnier S; Leroy BA; Hossle JP; Grez M; Dinauer MC
    Hum Gene Ther; 2003 May; 14(7):651-66. PubMed ID: 12804147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and use of a safe and efficient amphotropic packaging cell line.
    Markowitz D; Goff S; Bank A
    Virology; 1988 Dec; 167(2):400-6. PubMed ID: 2462307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.
    Campion Y; Paclet MH; Jesaitis AJ; Marques B; Grichine A; Berthier S; Lenormand JL; Lardy B; Stasia MJ; Morel F
    Biochimie; 2007 Sep; 89(9):1145-58. PubMed ID: 17397983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
    Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells.
    Saulnier SO; Steinhoff D; Dinauer MC; Zufferey R; Trono D; Seger RA; Hossle JP
    J Gene Med; 2000; 2(5):317-25. PubMed ID: 11045425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
    Rappa G; Anzanello F; Alexeyev M; Fodstad O; Lorico A
    Eur J Haematol; 2007 May; 78(5):440-8. PubMed ID: 17331133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.